|
CCT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65399996318894E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.01420000029474E-07 |
| Normal-vs-Stage2 |
1.24930000000578E-06 |
| Normal-vs-Stage3 |
4.30000002271669E-09 |
| Normal-vs-Stage4 |
1.128040E-02 |
| Stage1-vs-Stage2 |
2.007800E-01 |
| Stage1-vs-Stage3 |
3.243500E-02 |
| Stage1-vs-Stage4 |
4.536200E-01 |
| Stage2-vs-Stage3 |
6.472800E-01 |
| Stage2-vs-Stage4 |
1.381960E-01 |
| Stage3-vs-Stage4 |
4.348300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.9068999670493E-09 |
| Normal-vs-AfricanAmerican |
1.48779999997739E-06 |
| Normal-vs-Asian |
8.064300E-02 |
| Caucasian-vs-AfricanAmerican |
1.636190E-01 |
| Caucasian-vs-Asian |
7.913800E-01 |
| AfricanAmerican-vs-Asian |
4.418400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60649946071112E-10 |
| Normal-vs-Female |
9.60159999999766E-05 |
| Male-vs-Female |
1.161910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.094270E-02 |
| Normal-vs-Age(41-60Yrs) |
3.86640000016314E-08 |
| Normal-vs-Age(61-80Yrs) |
2.02499999990557E-07 |
| Normal-vs-Age(81-100Yrs) |
1.719610E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.948400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.078600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.666400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.848000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.726800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.684220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.927800E-02 |
| Normal-vs-Grade 2 |
2.10529999999931E-05 |
| Normal-vs-Grade 3 |
2.90489998722165E-09 |
| Normal-vs-Grade 4 |
1.179290E-04 |
| Grade 1-vs-Grade 2 |
9.981800E-01 |
| Grade 1-vs-Grade 3 |
5.020800E-01 |
| Grade 1-vs-Grade 4 |
3.719200E-01 |
| Grade 2-vs-Grade 3 |
4.410200E-02 |
| Grade 2-vs-Grade 4 |
2.092400E-01 |
| Grade 3-vs-Grade 4 |
8.725400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.24750000000263E-05 |
| Normal-vs-ccB subtype |
1.04779995790949E-09 |
| ccA subtype-vs-ccB subtype |
2.540900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.938100000487E-07 |
| Normal-vs-N1 |
5.006400E-01 |
| N0-vs-N1 |
4.764400E-01 |
|
|
